Generic-Drug Companies And Federal Preemption
Three recent district court decisions — from Minnesota, California and Florida — have created a division in the federal courts on whether products liability claims against generic pharmaceutical manufacturers are preempted...To view the full article, register now.
Already a subscriber? Click here to view full article